Evidence map›Paper›PMID 34186495›Full record

ArticleJournal of the neurological sciences2021

Potentials to alleviate coagulopathy and enhance microglial function of beta (β)- glucans, making them worth a clinical study for COVID-19's neurological sequalae.

Kadalraja Raghavan, Ramesh Shankar Kandaswamy, Nobunao Ikewaki, Masaru Iwasaki, Samuel J K Abraham

Abstract readLetter
In one paragraph

Article in Journal of the neurological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Transient global amnesia and Covid-19.Journal of the neurological sciences · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kadalraja RaghavanDepartment of Paediatric Neurology, Sarvee Integra Private Limited, Chennai, India. Electronic address: drkraghavan27@gmail.com.
Ramesh Shankar KandaswamyConsultant Psychiatrist & Clinical Director, Lincolnshire Partnership NHS Foundation Trust, United Kingdom.
Nobunao IkewakiDept. of Medical Life Science, Kyushu University of Health and Welfare, Japan; Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan.
Masaru IwasakiCentre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan.
Samuel J K AbrahamCentre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan; Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India; Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan. Electronic address: drsam@nichimail.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

beta-GlucansCOVID-19HumansMicrogliaSARS-CoV-2beta-GlucansBeta glucanCOVID-19MicrogliaNeurological sequalaeNutritional supplement

Identifiers

PMID34186495
PMCPMC8219294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.